WO2002001228A8 - Interaction of colloid-immobilized species with species on non-colloidal structures - Google Patents

Interaction of colloid-immobilized species with species on non-colloidal structures

Info

Publication number
WO2002001228A8
WO2002001228A8 PCT/US2001/020168 US0120168W WO0201228A8 WO 2002001228 A8 WO2002001228 A8 WO 2002001228A8 US 0120168 W US0120168 W US 0120168W WO 0201228 A8 WO0201228 A8 WO 0201228A8
Authority
WO
WIPO (PCT)
Prior art keywords
species
colloid
interaction
immobilized
colloidal structures
Prior art date
Application number
PCT/US2001/020168
Other languages
French (fr)
Other versions
WO2002001228A2 (en
Inventor
Cynthia C Bamdad
R Shoshana Bamdad
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Priority to JP2002506110A priority Critical patent/JP2004512497A/en
Priority to AU7014001A priority patent/AU7014001A/en
Priority to EP01948690A priority patent/EP1309858A2/en
Priority to CA002413932A priority patent/CA2413932A1/en
Publication of WO2002001228A2 publication Critical patent/WO2002001228A2/en
Publication of WO2002001228A8 publication Critical patent/WO2002001228A8/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/004Enzyme electrodes mediator-assisted
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2610/00Assays involving self-assembled monolayers [SAMs]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
PCT/US2001/020168 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures WO2002001228A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002506110A JP2004512497A (en) 2000-06-23 2001-06-25 Interaction of colloid-fixed species with species on non-colloidal structures
AU7014001A AU7014001A (en) 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures
EP01948690A EP1309858A2 (en) 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures
CA002413932A CA2413932A1 (en) 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60277800A 2000-06-23 2000-06-23
US09/602,778 2000-06-23

Publications (2)

Publication Number Publication Date
WO2002001228A2 WO2002001228A2 (en) 2002-01-03
WO2002001228A8 true WO2002001228A8 (en) 2003-03-06

Family

ID=24412766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020168 WO2002001228A2 (en) 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures

Country Status (5)

Country Link
EP (1) EP1309858A2 (en)
JP (1) JP2004512497A (en)
AU (1) AU7014001A (en)
CA (1) CA2413932A1 (en)
WO (1) WO2002001228A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585682B2 (en) 2000-10-03 2009-09-08 Minerva Biotechologies Corporation Magnetic in situ dilution
DE10109777A1 (en) * 2001-03-01 2002-09-19 Infineon Technologies Ag Method for detecting macromolecular biopolymers using at least one unit for immobilizing macromolecular biopolymers
DE10214719A1 (en) * 2002-04-03 2003-11-20 Infineon Technologies Ag Sensor for the qualitative and quantitative determination of (bio) organic oligomers and polymers, analysis methods for this as well as methods for producing the sensor
GB2391230A (en) * 2002-07-26 2004-02-04 Smartbead Technologies Ltd Multiparameter assays using coded supports
US7041401B2 (en) 2002-10-18 2006-05-09 University Of Iowa Research Foundation Magnetically modified electrodes containing at least one catalyst component that mediates a subatomic particle transfer process
CN1761878B (en) * 2003-03-14 2012-04-11 财团法人北九州产业学术推进机构 Organic substance immobilizing chip and its use
US7604982B2 (en) 2003-11-29 2009-10-20 Proteogen Inc. High-throughput screening method for intergrin antagonist and new peptide screened therefrom
JP4941551B2 (en) * 2007-03-30 2012-05-30 富士通株式会社 Organic substance detection device and manufacturing method thereof
SE532583C2 (en) * 2008-04-24 2010-02-23 Svanova Biotech Ab Gold-containing molecular aggregates for the detection of chemical and biochemical species
WO2018111941A1 (en) * 2016-12-12 2018-06-21 13.8, Inc. Compositions of high affinity reagents and methods of use thereof
EP3460472A1 (en) * 2017-09-22 2019-03-27 Nokia Technologies Oy Functionalised particles
CN110078829B (en) * 2019-04-29 2021-01-15 大连理工大学 Histidine-tagged protein fixed-point covalent immobilization method based on vinyl sulfone surface reaction
WO2021210189A1 (en) * 2020-04-18 2021-10-21 有限会社マイテック Pathogen quantum crystal solid-phase substrate and quantum crystal solid-phase fluorescence counting method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0750112B2 (en) * 1988-04-26 1995-05-31 日本電信電話株式会社 Sample preparation method for carrying out laser magnetic immunoassay method
IL85137A (en) * 1987-01-21 1992-02-16 Ares Serono Res & Dev Ltd Method of assaying for a ligand using surface plasmon resonance effect
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
JPH1132764A (en) * 1997-07-14 1999-02-09 Yakult Honsha Co Ltd Monoclonal antibody for bifidobacterium breve

Also Published As

Publication number Publication date
JP2004512497A (en) 2004-04-22
EP1309858A2 (en) 2003-05-14
AU7014001A (en) 2002-01-08
WO2002001228A2 (en) 2002-01-03
CA2413932A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2001231752A1 (en) Cook-top
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001278755A1 (en) Injections
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001266345A1 (en) Five-membered-ring compound
AU2001231682A1 (en) Surfactant combination
WO2002001228A8 (en) Interaction of colloid-immobilized species with species on non-colloidal structures
AU2001243394A1 (en) Compounds and methods
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001254731A1 (en) Substituted phenyluracils
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AUPQ872300A0 (en) Compounds and methods
AU4089601A (en) Panel
AU2001280039A1 (en) Ornamental panel
AU2001278951A1 (en) Compounds and methods
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2002235277A1 (en) Compounds and methods
AU2002221918A1 (en) Soundproof floor-filling structure
AU2002223604A1 (en) Substituted phenyluracils
AUPQ505800A0 (en) Structural assemblies
AU2002215021A1 (en) Fastening element
AU2001249886A1 (en) High q structure
AU2000235471A1 (en) Case with split panels
AU2000261825A1 (en) Protruding structure block

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001270140

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2413932

Country of ref document: CA

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2002 506110

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001948690

Country of ref document: EP

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2001948690

Country of ref document: EP